Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05419375 · ClinicalTrials.gov registry record · Phase 2
Screening Study for Participants With Malignant Tumors
A Phase 2 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 2
- Development phase
- 470
- Enrollment target
NCT05419375 is a Phase 2 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 470 participants.
The verdict
NCT05419375, a Phase 2 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 470 participants
- Enrollment target
Study Summary
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
Interventions
- OTHER Screening platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2025-09-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05419375
The ClinicalTrials.gov registry entry for NCT05419375 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 470 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screening platform is the first listed.
NCT05419375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05419375 about?
NCT05419375 is a clinical study titled "Screening Study for Participants With Malignant Tumors". The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
What is the current status of trial NCT05419375?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 470 participants. The study started on 2022-07-22. Estimated completion is 2025-09-03.
What interventions are being tested in trial NCT05419375?
The interventions under investigation include: Screening platform (OTHER).
Who is sponsoring clinical trial NCT05419375?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.